David Mitchell

by Jasmine Batchelor

December 20, 2017

Founder and President,
Patients for Affordable Drugs

David Mitchell has an incurable blood cancer called multiple myeloma. The price of his current drugs is $450,000 per year. Like millions of others, David needs innovation and new drugs for his survival, but he believes drugs don’t work if people can’t afford them. After more than 30 years at a D.C. policy communications firm, he retired in December 2016 to devote his full energy to helping change policy to lower prescription drug prices. Patients For Affordable Drugs mobilizes patients and allies at the federal and state levels and does not accept funding from any organizations that profit from the development or distribution of prescription drugs.